グローバル中等度から重度の尋常性乾癬の治療薬市場規模、主要企業シェア、ランキング分析レポート【2026年版】
Moderate to Severe Plaque Psoriasis Medications - Global Top Players Market Share and Ranking 2026
- レポートID：224097
- 発表時期：2026-03-03
- レポート形式：PDF
- 産業カテゴリー：薬品及びサプリメント
- レポート言語：英語、日本語
- ページ数：109
- 発行会社（調査会社）：YHResearch
言語とエディションの価格
- 英語版
- 日本語版
- 英語と日本語版
個人版詳細
マルチユーザー版詳細
企業版詳細
- 英語版
- 日本語版
- 英語と日本語版
価格表記: USDを日本円(税抜)に換算，本日の銀行送金レート: 1USD=162.40円。
※米ドル表示価格+10％消費税。
※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。
レポートの概要
本報告書は、世界の中等度から重度の尋常性乾癬の治療薬市場について包括的な分析を行い、市場全体の動向を明らかにすることを目的としています。総販売数量、売上高、価格動向に加え、主要企業の市場シェアおよび順位を整理し、市場構造を多角的に把握します。さらに、地域・国別、製品タイプ別、用途分野別などの観点から中等度から重度の尋常性乾癬の治療薬市場を分析し、需要構造と成長特性を明確化します。
中等度から重度の尋常性乾癬の治療薬市場の規模、推定値および予測は、2025年を基準年とし、2021年から2032年までの期間における販売数量および売上高に基づいて提示しています。定量分析と定性分析を組み合わせることで、ビジネスおよび成長戦略を検討し、市場競争環境を評価し、企業の市場ポジションを把握した上で、中等度から重度の尋常性乾癬の治療薬に関する的確な意思決定を行うための実践的なインサイトを提供します。
主要中等度から重度の尋常性乾癬の治療薬市場の統計
2025年世界市場規模：百万米ドル
2026年世界市場規模：百万米ドル
2032年予測市場規模：百万米ドル
2026–2032年予測期間CAGR：
本レポートは中等度から重度の尋常性乾癬の治療薬市場の中長期的な成長動向を定量分析および定性分析の両面から体系的に整理しています。
【市場セグメンテーション】
主要企業・競争環境
中等度から重度の尋常性乾癬の治療薬市場の主要企業には以下が含まれます：
Janssen Biotech
Abbvie
Sandoz
Amgen
Eli Lilly
Novartis
Sun Pharmaceutical Industries
UCB, Inc
Dermavant Sciences
GSK
製品別
Injection
Oral
Topical Cream
アプリケーション別
Hospital Clinic
Pharmacy
Online Shopping Mall
レポート対象地域
北米：アメリカ、カナダ、その他
アジア太平洋：中国、日本、韓国、東南アジア、インド、オーストラリア、その他
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、オランダ、北欧諸国、その他
ラテンアメリカ：メキシコ、ブラジル、その他
中東・アフリカ：トルコ、サウジアラビア、UAE、その他
レポート構成（章別概要）
第1章｜市場概要と成長展望
中等度から重度の尋常性乾癬の治療薬市場の全体像を整理し、市場規模、売上予測、価格推移を体系的に解説します。同時に成長要因、市場機会、業界課題、リスク要因を分析し、中長期的な市場展望を提示します
第2章｜主要企業の競争分析
中等度から重度の尋常性乾癬の治療薬市場における主要プレイヤー（トップ5社・トップ10社）を対象に、売上高、製造拠点、製品構成、価格戦略、販売量、市場シェアを多面的に分析し、競争構造を明確化します
第3章｜製品カテゴリ別市場動向
製品タイプ別に中等度から重度の尋常性乾癬の治療薬市場を分類し、売上高、市場シェア、販売量、価格動向を分析します。成長性の高い製品分野と市場構造の変化を明らかにします
第4章｜用途別市場動向
用途別に中等度から重度の尋常性乾癬の治療薬市場規模、売上高、市場シェア、販売量、価格推移を整理し、業界別の需要動向と成長ポテンシャルを分析します
第5章｜地域別市場分析
地域別の市場成長率、販売量、売上高を詳細に分析し、中等度から重度の尋常性乾癬の治療薬市場の地理的需要構造を可視化します。各地域の市場規模推移と将来の成長余地を評価します
第6章｜国別市場動向
主要国・地域ごとに、中等度から重度の尋常性乾癬の治療薬市場の販売量、売上高、成長要因、政策・規制環境、競争特性を整理し、国別市場の特徴を明確にします
第7章｜主要企業プロファイル
中等度から重度の尋常性乾癬の治療薬市場を牽引する主要企業について、売上高、販売量、価格動向、粗利益率、製品ポートフォリオ、最新の戦略動向を詳細に解説します
第8章｜バリューチェーンと市場構造分析
業界全体のサプライチェーンを上流から下流まで整理し、コスト構造や流通モデルの動向を分析します
第9章｜調査結果
調査結果を総括し、市場全体のトレンド、今後の成長機会、潜在的リスク、戦略的な洞察を提示します
第10章｜付録（調査手法・データソース）
調査設計、分析手法、使用データソースの詳細を明示し、レポートの信頼性と透明性を担保します
本レポートの要点と洞察
中等度から重度の尋常性乾癬の治療薬市場の全体像と成長見通し
中等度から重度の尋常性乾癬の治療薬市場の規模変化の傾向、成長予測及び需要動向を体系的に整理いたします。2021年から2025年までの実績データに基づき、2032年までの中長期予測を提示し、市場の拡大速度と成長潜在力を明らかにします。同時に、最近の関税調整措置など各国の政策動向を踏まえ、多角的にグローバル経済環境が中等度から重度の尋常性乾癬の治療薬市場に与える影響を分析いたします
市場環境の構成要素とマクロトレンド
中等度から重度の尋常性乾癬の治療薬産業を取り巻く市場環境について、需要構造の変化、政策対応、技術革新の進展といった主要要因を整理します。特に、国際貿易政策や関税政策の変化が企業戦略や価格形成に及ぼす影響、サプライチェーン再編の動きと事業運営への波及効果を明確化し、市場環境の全体像を包括的に提示します
競争構造と主要企業の動向分析
中等度から重度の尋常性乾癬の治療薬市場における主要企業の売上規模、市場シェア、競争ポジションを整理し、競争構造の特徴を分析します。各社の競争戦略、事業拡大の方向性、新製品・新技術の投入動向を通じて、技術革新が市場競争に与える影響と競争環境の変化を解読します
競争環境と事業動向の把握
製品タイプ別、用途別、地域・国別の観点から中等度から重度の尋常性乾癬の治療薬市場のセグメント構造を整理します。各地域の需要構成と成長特性を比較分析し、各細分領域が市場全体の成長に与える貢献度と相互関連性を明確にします
成長要因・課題・リスクの分析
中等度から重度の尋常性乾癬の治療薬市場の成長を支える主要ドライバーを整理するとともに、業界特有の課題や潜在的リスクを分析します。原材料調達、供給システム、事業運営における不確実性を踏まえ、サプライチェーン及び事業レジリエンス強化の方向性についても考察します
将来トレンドと市場展望
中等度から重度の尋常性乾癬の治療薬市場の中長期的な成長トレンドと将来の発展シナリオを提示します。持続的成長を実現するための重要な成功要因を整理し、今後の市場参入企業や既存プレイヤーの戦略的意思決定に参考となる視点を提供いたします
Description
According to YH Research, the global market for Moderate to Severe Plaque Psoriasis Medications should grow from US$ million in 2025 to US$ million by 2032, with a CAGR of %for the period of 2026-2032.
The strategic recalibration of 2025 U.S. tariff mechanisms is redefining global economic governance norms. This study deciphers the transmission mechanisms of tariff escalation pathways and global policy responses on corporate investment strategies, regional trade networks, and critical material supply architectures.
The driving factors for moderate to severe plaque psoriasis drugs mainly include the following aspects:
Disease severity: Patients with moderate to severe plaque psoriasis have a more severe condition and require medication to control the progression of the disease and relieve symptoms. Therefore, there is a high demand for drugs for moderate to severe plaque psoriasis, which promotes the development and application of related drugs.
Medical needs: Psoriasis is a chronic, relapsing, inflammatory skin disease that requires long-term treatment and management. Therefore, the increase in medical demand has also promoted the development and application of drugs for moderate to severe plaque psoriasis.
Development of science and technology: With the continuous advancement of science and technology, new drugs and technical means are constantly emerging, providing more possibilities and opportunities for the development and application of drugs for moderate to severe plaque psoriasis. For example, new drug formulations, delivery methods, treatment methods, etc. can improve treatment effects and patient compliance.
Policy support: The government and regulatory agencies provide policy support for the research, development and application of innovative drugs and encourage pharmaceutical companies to conduct research and development. This also provides more opportunities and resources for the research, development and application of drugs for moderate to severe plaque psoriasis. .
Market demand: As the number of psoriasis patients continues to increase, the market demand is also growing. The demand from patients and doctors for drugs with better therapeutic effects has also driven the development and application of drugs for moderate to severe plaque psoriasis.
This report studies and analyses global Moderate to Severe Plaque Psoriasis Medications status and future trends, helps the client to determine the Moderate to Severe Plaque Psoriasis Medications market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Moderate to Severe Plaque Psoriasis Medications, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2025 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Moderate to Severe Plaque Psoriasis Medications market size, history data 2021-2025, and forecast data 2026-2032, (US$ million) & (K Units)
(2) Global Moderate to Severe Plaque Psoriasis Medications sales, revenue, price by company, market share and industry ranking 2021-2026, (US$ million) & (K Units)
(3) Japan Moderate to Severe Plaque Psoriasis Medications sales, revenue, price by company, market share and industry ranking 2021-2026, (US$ million) & (K Units)
(4) Global Moderate to Severe Plaque Psoriasis Medications key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Moderate to Severe Plaque Psoriasis Medications key producing regions, capacity, production, and year over year growth
(6) Moderate to Severe Plaque Psoriasis Medications industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Janssen Biotech
Abbvie
Sandoz
Amgen
Eli Lilly
Novartis
Sun Pharmaceutical Industries
UCB, Inc
Dermavant Sciences
GSK
Market segment by Type, covers
Injection
Oral
Topical Cream
Market segment by Application, can be divided into
Hospital Clinic
Pharmacy
Online Shopping Mall
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Moderate to Severe Plaque Psoriasis Medications product scope, global sales quantity, value and average price, Japan sales quantity, value and average price, development opportunities, challenges, trends, and policies
Chapter 2: Global Moderate to Severe Plaque Psoriasis Medications market share and ranking of major manufacturers, sales quantity, revenue, average price, 2021-2026
Chapter 3: Japan Moderate to Severe Plaque Psoriasis Medications market share and ranking of major manufacturers, sales quantity, revenue, average price, 2021-2026
Chapter 4: Global key producing regions of Moderate to Severe Plaque Psoriasis Medications, percent & CAGR, 2021-2032
Chapter 5: Moderate to Severe Plaque Psoriasis Medications industry chain, upstream, medium-stream, and downstream
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2021-2032
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2021-2032
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2021-2032
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2021-2032
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin
Chapter 11: Conclusions
Table of Contents
1 Market Overview
1.1 Moderate to Severe Plaque Psoriasis Medications Definition
1.2 Global Moderate to Severe Plaque Psoriasis Medications Market Size and Forecast
1.2.1 By Consumption Value, Global Moderate to Severe Plaque Psoriasis Medications Market Size, 2021-2032
1.2.2 By Sales Quantity, Global Moderate to Severe Plaque Psoriasis Medications Market Size, 2021-2032
1.2.3 Global Moderate to Severe Plaque Psoriasis Medications Average Selling Price (ASP), 2021-2032
1.3 Japan Moderate to Severe Plaque Psoriasis Medications Market Size and Forecast
1.3.1 By Consumption Value, Japan Moderate to Severe Plaque Psoriasis Medications Market Size, 2021-2032
1.3.2 By Sales Quantity, Japan Moderate to Severe Plaque Psoriasis Medications Market Size, 2021-2032
1.3.3 Japan Moderate to Severe Plaque Psoriasis Medications Average Selling Price (ASP), 2021-2032
1.4 Share of Japan Moderate to Severe Plaque Psoriasis Medications Market with Respect to the Global Market
1.4.1 By Consumption Value, Japan Moderate to Severe Plaque Psoriasis Medications Market Share in Global, 2021-2032
1.4.2 By Sales Quantity, Japan Moderate to Severe Plaque Psoriasis Medications Market Share in Global, 2021-2032
1.4.3 Moderate to Severe Plaque Psoriasis Medications Market Size: Japan VS Global, 2021-2032
1.5 Moderate to Severe Plaque Psoriasis Medications Market Dynamics
1.5.1 Moderate to Severe Plaque Psoriasis Medications Market Drivers
1.5.2 Moderate to Severe Plaque Psoriasis Medications Market Restraints
1.5.3 Moderate to Severe Plaque Psoriasis Medications Industry Trends
1.5.4 Moderate to Severe Plaque Psoriasis Medications Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Moderate to Severe Plaque Psoriasis Medications, Global Market Share by Company, 2021-2026
2.2 By Sales Quantity of Moderate to Severe Plaque Psoriasis Medications, Global Market Share by Company, 2021-2026
2.3 Moderate to Severe Plaque Psoriasis Medications Average Selling Price (ASP) by Company, 2021-2026
2.4 Global Moderate to Severe Plaque Psoriasis Medications Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Moderate to Severe Plaque Psoriasis Medications Concentration Ratio
2.6 Global Moderate to Severe Plaque Psoriasis Medications Mergers & Acquisitions, Expansion Plans
2.7 Global Moderate to Severe Plaque Psoriasis Medications Manufacturers Product Type
2.8 Head Office and Moderate to Severe Plaque Psoriasis Medications Production Site of Key Manufacturer
2.9 Moderate to Severe Plaque Psoriasis Medications Capacity of Major Manufacturers and Future Plan
3 Japan Leading Manufacturers and Market Share
3.1 By Revenue of Moderate to Severe Plaque Psoriasis Medications, Japan Market Share by Company, 2021-2026
3.2 By Sales Quantity of Moderate to Severe Plaque Psoriasis Medications, Japan Market Share by Company, 2021-2026
3.3 Japan Moderate to Severe Plaque Psoriasis Medications Moderate to Severe Plaque Psoriasis Medications Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Moderate to Severe Plaque Psoriasis Medications Capacity, Output and Capacity Utilization, 2021-2032
4.2 Global Moderate to Severe Plaque Psoriasis Medications Capacity by Region
4.3 Global Moderate to Severe Plaque Psoriasis Medications Production & Forecast by Region, 2021 VS 2025 VS 2032
4.4 Global Moderate to Severe Plaque Psoriasis Medications Production by Region, 2021-2032
4.5 Global Moderate to Severe Plaque Psoriasis Medications Production Market Share & Forecast by Region, 2021-2032
5 Industry Chain Analysis
5.1 Moderate to Severe Plaque Psoriasis Medications Industry Chain
5.2 Moderate to Severe Plaque Psoriasis Medications Upstream Analysis
5.2.1 Moderate to Severe Plaque Psoriasis Medications Core Raw Materials
5.2.2 Main Manufacturers of Moderate to Severe Plaque Psoriasis Medications Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Moderate to Severe Plaque Psoriasis Medications Production Mode
5.6 Moderate to Severe Plaque Psoriasis Medications Procurement Model
5.7 Moderate to Severe Plaque Psoriasis Medications Industry Sales Model and Sales Channels
5.7.1 Moderate to Severe Plaque Psoriasis Medications Sales Model
5.7.2 Moderate to Severe Plaque Psoriasis Medications Typical Distributors
6 Sights by Type
6.1 Moderate to Severe Plaque Psoriasis Medications Classification by Type
6.1.1 Injection
6.1.2 Oral
6.1.3 Topical Cream
6.2 by Type, Global Moderate to Severe Plaque Psoriasis Medications Consumption Value & CAGR, 2021 VS 2025 VS 2032
6.3 by Type, Global Moderate to Severe Plaque Psoriasis Medications Consumption Value, 2021-2032
6.4 by Type, Global Moderate to Severe Plaque Psoriasis Medications Sales Quantity, 2021-2032
6.5 by Type, Global Moderate to Severe Plaque Psoriasis Medications Average Selling Price (ASP), 2021-2032
7 Sights by Application
7.1 Moderate to Severe Plaque Psoriasis Medications Segment by Application
7.1.1 Hospital Clinic
7.1.2 Pharmacy
7.1.3 Online Shopping Mall
7.2 by Application, Global Moderate to Severe Plaque Psoriasis Medications Consumption Value & CAGR, 2021 VS 2025 VS 2032
7.3 by Application, Global Moderate to Severe Plaque Psoriasis Medications Consumption Value, 2021-2032
7.4 by Application, Global Moderate to Severe Plaque Psoriasis Medications Sales Quantity, 2021-2032
7.5 by Application, Global Moderate to Severe Plaque Psoriasis Medications Price, 2021-2032
8 Sales Sights by Region
8.1 By Region, Global Moderate to Severe Plaque Psoriasis Medications Consumption Value, 2021 VS 2025 VS 2032
8.2 By Region, Global Moderate to Severe Plaque Psoriasis Medications Consumption Value, 2021-2032
8.3 By Region, Global Moderate to Severe Plaque Psoriasis Medications Sales Quantity, 2021-2032
8.4 North America
8.4.1 North America Moderate to Severe Plaque Psoriasis Medications Market Size & Forecasts, 2021-2032
8.4.2 By Country, North America Moderate to Severe Plaque Psoriasis Medications Market Size Market Share
8.5 Europe
8.5.1 Europe Moderate to Severe Plaque Psoriasis Medications Market Size & Forecasts, 2021-2032
8.5.2 By Country, Europe Moderate to Severe Plaque Psoriasis Medications Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Moderate to Severe Plaque Psoriasis Medications Market Size & Forecasts, 2021-2032
8.6.2 By Country/Region, Asia Pacific Moderate to Severe Plaque Psoriasis Medications Market Size Market Share
8.7 South America
8.7.1 South America Moderate to Severe Plaque Psoriasis Medications Market Size & Forecasts, 2021-2032
8.7.2 By Country, South America Moderate to Severe Plaque Psoriasis Medications Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Moderate to Severe Plaque Psoriasis Medications Market Size & CAGR, 2021 VS 2025 VS 2032
9.2 By Country, Global Moderate to Severe Plaque Psoriasis Medications Consumption Value, 2021-2032
9.3 By Country, Global Moderate to Severe Plaque Psoriasis Medications Sales Quantity, 2021-2032
9.4 United States
9.4.1 United States Moderate to Severe Plaque Psoriasis Medications Market Size, 2021-2032
9.4.2 by Type, United States Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share, 2025 VS 2032
9.4.3 by Application, United States Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share, 2025 VS 2032
9.5 Europe
9.5.1 Europe Moderate to Severe Plaque Psoriasis Medications Market Size, 2021-2032
9.5.2 by Type, Europe Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share, 2025 VS 2032
9.5.3 by Application, Europe Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share, 2025 VS 2032
9.6 China
9.6.1 China Moderate to Severe Plaque Psoriasis Medications Market Size, 2021-2032
9.6.2 by Type, China Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share, 2025 VS 2032
9.6.3 by Application, China Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share, 2025 VS 2032
9.7 Japan
9.7.1 Japan Moderate to Severe Plaque Psoriasis Medications Market Size, 2021-2032
9.7.2 by Type, Japan Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share, 2025 VS 2032
9.7.3 by Application, Japan Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share, 2025 VS 2032
9.8 South Korea
9.8.1 South Korea Moderate to Severe Plaque Psoriasis Medications Market Size, 2021-2032
9.8.2 by Type, South Korea Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share, 2025 VS 2032
9.8.3 by Application, South Korea Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share, 2025 VS 2032
9.9 Southeast Asia
9.9.1 Southeast Asia Moderate to Severe Plaque Psoriasis Medications Market Size, 2021-2032
9.9.2 by Type, Southeast Asia Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share, 2025 VS 2032
9.9.3 by Application, Southeast Asia Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share, 2025 VS 2032
9.10 India
9.10.1 India Moderate to Severe Plaque Psoriasis Medications Market Size, 2021-2032
9.10.2 by Type, India Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share, 2025 VS 2032
9.10.3 by Application, India Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share, 2025 VS 2032
9.11 Middle East & Africa
9.11.1 Middle East & Africa Moderate to Severe Plaque Psoriasis Medications Market Size, 2021-2032
9.11.2 by Type, Middle East & Africa Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share, 2025 VS 2032
9.11.3 by Application, Middle East & Africa Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share, 2025 VS 2032
10 Manufacturers Profile
10.1 Janssen Biotech
10.1.1 Janssen Biotech Company Information, Head Office, Market Area, and Industry Position
10.1.2 Janssen Biotech Moderate to Severe Plaque Psoriasis Medications Models, Specifications, and Application
10.1.3 Janssen Biotech Moderate to Severe Plaque Psoriasis Medications Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.1.4 Janssen Biotech Company Profile and Main Business
10.1.5 Janssen Biotech Recent Developments
10.2 Abbvie
10.2.1 Abbvie Company Information, Head Office, Market Area, and Industry Position
10.2.2 Abbvie Moderate to Severe Plaque Psoriasis Medications Models, Specifications, and Application
10.2.3 Abbvie Moderate to Severe Plaque Psoriasis Medications Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.2.4 Abbvie Company Profile and Main Business
10.2.5 Abbvie Recent Developments
10.3 Sandoz
10.3.1 Sandoz Company Information, Head Office, Market Area, and Industry Position
10.3.2 Sandoz Moderate to Severe Plaque Psoriasis Medications Models, Specifications, and Application
10.3.3 Sandoz Moderate to Severe Plaque Psoriasis Medications Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.3.4 Sandoz Company Profile and Main Business
10.3.5 Sandoz Recent Developments
10.4 Amgen
10.4.1 Amgen Company Information, Head Office, Market Area, and Industry Position
10.4.2 Amgen Moderate to Severe Plaque Psoriasis Medications Models, Specifications, and Application
10.4.3 Amgen Moderate to Severe Plaque Psoriasis Medications Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.4.4 Amgen Company Profile and Main Business
10.4.5 Amgen Recent Developments
10.5 Eli Lilly
10.5.1 Eli Lilly Company Information, Head Office, Market Area, and Industry Position
10.5.2 Eli Lilly Moderate to Severe Plaque Psoriasis Medications Models, Specifications, and Application
10.5.3 Eli Lilly Moderate to Severe Plaque Psoriasis Medications Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.5.4 Eli Lilly Company Profile and Main Business
10.5.5 Eli Lilly Recent Developments
10.6 Novartis
10.6.1 Novartis Company Information, Head Office, Market Area, and Industry Position
10.6.2 Novartis Moderate to Severe Plaque Psoriasis Medications Models, Specifications, and Application
10.6.3 Novartis Moderate to Severe Plaque Psoriasis Medications Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.6.4 Novartis Company Profile and Main Business
10.6.5 Novartis Recent Developments
10.7 Sun Pharmaceutical Industries
10.7.1 Sun Pharmaceutical Industries Company Information, Head Office, Market Area, and Industry Position
10.7.2 Sun Pharmaceutical Industries Moderate to Severe Plaque Psoriasis Medications Models, Specifications, and Application
10.7.3 Sun Pharmaceutical Industries Moderate to Severe Plaque Psoriasis Medications Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.7.4 Sun Pharmaceutical Industries Company Profile and Main Business
10.7.5 Sun Pharmaceutical Industries Recent Developments
10.8 UCB, Inc
10.8.1 UCB, Inc Company Information, Head Office, Market Area, and Industry Position
10.8.2 UCB, Inc Moderate to Severe Plaque Psoriasis Medications Models, Specifications, and Application
10.8.3 UCB, Inc Moderate to Severe Plaque Psoriasis Medications Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.8.4 UCB, Inc Company Profile and Main Business
10.8.5 UCB, Inc Recent Developments
10.9 Dermavant Sciences
10.9.1 Dermavant Sciences Company Information, Head Office, Market Area, and Industry Position
10.9.2 Dermavant Sciences Moderate to Severe Plaque Psoriasis Medications Models, Specifications, and Application
10.9.3 Dermavant Sciences Moderate to Severe Plaque Psoriasis Medications Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.9.4 Dermavant Sciences Company Profile and Main Business
10.9.5 Dermavant Sciences Recent Developments
10.10 GSK
10.10.1 GSK Company Information, Head Office, Market Area, and Industry Position
10.10.2 GSK Moderate to Severe Plaque Psoriasis Medications Models, Specifications, and Application
10.10.3 GSK Moderate to Severe Plaque Psoriasis Medications Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.10.4 GSK Company Profile and Main Business
10.10.5 GSK Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table of Figures
List of Tables Table 1. Moderate to Severe Plaque Psoriasis Medications Consumption Value & CAGR: Japan VS Global, 2021-2032, US$ Million Table 2. Moderate to Severe Plaque Psoriasis Medications Market Restraints Table 3. Moderate to Severe Plaque Psoriasis Medications Market Trends Table 4. Moderate to Severe Plaque Psoriasis Medications Industry Policy Table 5. Global Moderate to Severe Plaque Psoriasis Medications Revenue by Company, 2021-2026, US$ million, Ranked Based on Revenue in 2025 Table 6. Global Moderate to Severe Plaque Psoriasis Medications Revenue Share by Company, 2021-2026, Ranked by Data of 2025 Table 7. Global Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Company, (2021-2026) & (K Units), Ranked Based on Sales in 2025 Table 8. Global Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share by Company, 2021-2026, Ranked by Data of 2025 Table 9. Global Moderate to Severe Plaque Psoriasis Medications Average Selling Price (ASP) by Company, (2021-2026) & (US$/Unit) Table 10. Global Moderate to Severe Plaque Psoriasis Medications Manufacturers Market Concentration Ratio (CR3 and HHI) Table 11. Global Moderate to Severe Plaque Psoriasis Medications Mergers & Acquisitions, Expansion Plans Table 12. Global Moderate to Severe Plaque Psoriasis Medications Manufacturers Product Type Table 13. Head Office and Moderate to Severe Plaque Psoriasis Medications Production Site of Key Manufacturer Table 14. Moderate to Severe Plaque Psoriasis Medications Capacity of Major Manufacturers and Future Plan Table 15. Japan Moderate to Severe Plaque Psoriasis Medications Revenue by Company, 2021-2026, US$ million, Ranked Based on Revenue in 2025 Table 16. Japan Moderate to Severe Plaque Psoriasis Medications Revenue Share by Company, 2021-2026, Ranked by Data of 2025 Table 17. Japan Moderate to Severe Plaque Psoriasis Medications Sales Quantity by Company, (2021-2026) & (K Units), Ranked Based on Sales in 2025 Table 18. Japan Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share by Company, 2021-2026, Ranked by Data of 2025 Table 19. Global Moderate to Severe Plaque Psoriasis Medications Production & Forecast by Region, 2021 VS 2025 VS 2032, (K Units) Table 20. Global Moderate to Severe Plaque Psoriasis Medications Production by Region, 2021-2026, (K Units) Table 21. Global Moderate to Severe Plaque Psoriasis Medications Production Forecast by Region, 2027-2032, (K Units) Table 22. Global Key Players of Moderate to Severe Plaque Psoriasis Medications Upstream (Raw Materials) Table 23. Global Moderate to Severe Plaque Psoriasis Medications Typical Customers Table 24. Moderate to Severe Plaque Psoriasis Medications Typical Distributors Table 25. by Type, Global Moderate to Severe Plaque Psoriasis Medications Consumption Value & CAGR, 2021 VS 2025 VS 2032, US$ Million Table 26. by Application, Global Moderate to Severe Plaque Psoriasis Medications Consumption Value & CAGR, 2021 VS 2025 VS 2032, US$ Million Table 27. By Region, Global Moderate to Severe Plaque Psoriasis Medications Consumption Value, 2021 VS 2025 VS 2032, US$ Million Table 28. By Region, Global Moderate to Severe Plaque Psoriasis Medications Consumption Value, 2021-2032, US$ Million Table 29. By Region, Global Moderate to Severe Plaque Psoriasis Medications Sales Quantity, 2021-2032, (K Units) Table 30. By Country, Global Moderate to Severe Plaque Psoriasis Medications Consumption Value & CAGR, 2021 VS 2025 VS 2032, US$ Million Table 31. By Country, Global Moderate to Severe Plaque Psoriasis Medications Consumption Value, 2021-2032, US$ Million Table 32. By Country, Global Moderate to Severe Plaque Psoriasis Medications Consumption Value Market Share, 2021-2032 Table 33. By Country, Global Moderate to Severe Plaque Psoriasis Medications Sales Quantity, 2021-2032, (K Units) Table 34. By Country, Global Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share, 2021-2032 Table 35. Janssen Biotech Company Information, Head Office, Market Area, and Industry Position Table 36. Janssen Biotech Moderate to Severe Plaque Psoriasis Medications Models, Specifications, and Application Table 37. Janssen Biotech Moderate to Severe Plaque Psoriasis Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026 Table 38. Janssen Biotech Company Profile and Main Business Table 39. Janssen Biotech Recent Developments Table 40. Abbvie Company Information, Head Office, Market Area, and Industry Position Table 41. Abbvie Moderate to Severe Plaque Psoriasis Medications Models, Specifications, and Application Table 42. Abbvie Moderate to Severe Plaque Psoriasis Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026 Table 43. Abbvie Company Profile and Main Business Table 44. Abbvie Recent Developments Table 45. Sandoz Company Information, Head Office, Market Area, and Industry Position Table 46. Sandoz Moderate to Severe Plaque Psoriasis Medications Models, Specifications, and Application Table 47. Sandoz Moderate to Severe Plaque Psoriasis Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026 Table 48. Sandoz Company Profile and Main Business Table 49. Sandoz Recent Developments Table 50. Amgen Company Information, Head Office, Market Area, and Industry Position Table 51. Amgen Moderate to Severe Plaque Psoriasis Medications Models, Specifications, and Application Table 52. Amgen Moderate to Severe Plaque Psoriasis Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026 Table 53. Amgen Company Profile and Main Business Table 54. Amgen Recent Developments Table 55. Eli Lilly Company Information, Head Office, Market Area, and Industry Position Table 56. Eli Lilly Moderate to Severe Plaque Psoriasis Medications Models, Specifications, and Application Table 57. Eli Lilly Moderate to Severe Plaque Psoriasis Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026 Table 58. Eli Lilly Company Profile and Main Business Table 59. Eli Lilly Recent Developments Table 60. Novartis Company Information, Head Office, Market Area, and Industry Position Table 61. Novartis Moderate to Severe Plaque Psoriasis Medications Models, Specifications, and Application Table 62. Novartis Moderate to Severe Plaque Psoriasis Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026 Table 63. Novartis Company Profile and Main Business Table 64. Novartis Recent Developments Table 65. Sun Pharmaceutical Industries Company Information, Head Office, Market Area, and Industry Position Table 66. Sun Pharmaceutical Industries Moderate to Severe Plaque Psoriasis Medications Models, Specifications, and Application Table 67. Sun Pharmaceutical Industries Moderate to Severe Plaque Psoriasis Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026 Table 68. Sun Pharmaceutical Industries Company Profile and Main Business Table 69. Sun Pharmaceutical Industries Recent Developments Table 70. UCB, Inc Company Information, Head Office, Market Area, and Industry Position Table 71. UCB, Inc Moderate to Severe Plaque Psoriasis Medications Models, Specifications, and Application Table 72. UCB, Inc Moderate to Severe Plaque Psoriasis Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026 Table 73. UCB, Inc Company Profile and Main Business Table 74. UCB, Inc Recent Developments Table 75. Dermavant Sciences Company Information, Head Office, Market Area, and Industry Position Table 76. Dermavant Sciences Moderate to Severe Plaque Psoriasis Medications Models, Specifications, and Application Table 77. Dermavant Sciences Moderate to Severe Plaque Psoriasis Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026 Table 78. Dermavant Sciences Company Profile and Main Business Table 79. Dermavant Sciences Recent Developments Table 80. GSK Company Information, Head Office, Market Area, and Industry Position Table 81. GSK Moderate to Severe Plaque Psoriasis Medications Models, Specifications, and Application Table 82. GSK Moderate to Severe Plaque Psoriasis Medications Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026 Table 83. GSK Company Profile and Main Business Table 84. GSK Recent Developments List of Figures Figure 1. Moderate to Severe Plaque Psoriasis Medications Picture Figure 2. Global Moderate to Severe Plaque Psoriasis Medications Consumption Value, (US$ million) & (2021-2032) Figure 3. Global Moderate to Severe Plaque Psoriasis Medications Sales Quantity, (K Units) & (2021-2032) Figure 4. Global Moderate to Severe Plaque Psoriasis Medications Average Selling Price (ASP), (2021-2032) & (US$/Unit) Figure 5. Japan Moderate to Severe Plaque Psoriasis Medications Consumption Value, (US$ million) & (2021-2032) Figure 6. Japan Moderate to Severe Plaque Psoriasis Medications Sales Quantity (K Units) & (2021-2032) Figure 7. Japan Moderate to Severe Plaque Psoriasis Medications Average Selling Price (ASP), (US$/Unit) & (2021-2032) Figure 8. By Consumption Value, Japan Moderate to Severe Plaque Psoriasis Medications Market Share of Global, 2021-2032 Figure 9. By Sales Quantity, Japan Moderate to Severe Plaque Psoriasis Medications Market Share of Global, 2021-2032 Figure 10. Global Moderate to Severe Plaque Psoriasis Medications Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2025 Figure 11. Japan Moderate to Severe Plaque Psoriasis Medications Key Participants, Market Share, 2025 Figure 12. Global Moderate to Severe Plaque Psoriasis Medications Capacity, Production and Capacity Utilization, 2021-2032 Figure 13. Global Moderate to Severe Plaque Psoriasis Medications Capacity Market Share by Region, 2025 VS 2032 Figure 14. Global Moderate to Severe Plaque Psoriasis Medications Production Market Share & Forecast by Region, 2021-2032 Figure 15. Moderate to Severe Plaque Psoriasis Medications Industry Chain Figure 16. Moderate to Severe Plaque Psoriasis Medications Procurement Model Figure 17. Moderate to Severe Plaque Psoriasis Medications Sales Model Figure 18. Moderate to Severe Plaque Psoriasis Medications Sales Channels, Direct Sales, and Distribution Figure 19. Injection Figure 20. Oral Figure 21. Topical Cream Figure 22. by Type, Global Moderate to Severe Plaque Psoriasis Medications Consumption Value, 2021-2032, US$ Million Figure 23. by Type, Global Moderate to Severe Plaque Psoriasis Medications Consumption Value Market Share, 2021-2032 Figure 24. by Type, Global Moderate to Severe Plaque Psoriasis Medications Sales Quantity, 2021-2032, (K Units) Figure 25. by Type, Global Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share, 2021-2032 Figure 26. by Type, Global Moderate to Severe Plaque Psoriasis Medications Average Selling Price (ASP), 2021-2032, (US$/Unit) Figure 27. Hospital Clinic Figure 28. Pharmacy Figure 29. Online Shopping Mall Figure 30. by Application, Global Moderate to Severe Plaque Psoriasis Medications Consumption Value, 2021-2032, US$ Million Figure 31. by Application, Global Moderate to Severe Plaque Psoriasis Medications Revenue Market Share, 2021-2032 Figure 32. by Application, Global Moderate to Severe Plaque Psoriasis Medications Sales Quantity, 2021-2032, (K Units) Figure 33. by Application, Global Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share, 2021-2032 Figure 34. by Application, Global Moderate to Severe Plaque Psoriasis Medications Price, 2021-2032, (US$/Unit) Figure 35. By Region, Global Moderate to Severe Plaque Psoriasis Medications Consumption Value Market Share, 2021-2032 Figure 36. By Region, Global Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share, 2021-2032 Figure 37. North America Moderate to Severe Plaque Psoriasis Medications Consumption Value & Forecasts, 2021-2032, US$ Million Figure 38. By Country, North America Moderate to Severe Plaque Psoriasis Medications Consumption Value Market Share, 2025 Figure 39. Europe Moderate to Severe Plaque Psoriasis Medications Consumption Value & Forecasts, 2021-2032, US$ Million Figure 40. By Country, Europe Moderate to Severe Plaque Psoriasis Medications Consumption Value Market Share, 2025 Figure 41. Asia Pacific Moderate to Severe Plaque Psoriasis Medications Consumption Value & Forecasts, 2021-2032, US$ Million Figure 42. By Country/Region, Asia Pacific Moderate to Severe Plaque Psoriasis Medications Consumption Value Market Share, 2025 Figure 43. South America Moderate to Severe Plaque Psoriasis Medications Consumption Value & Forecasts, 2021-2032, US$ Million Figure 44. By Country, South America Moderate to Severe Plaque Psoriasis Medications Consumption Value Market Share, 2025 Figure 45. Middle East & Africa Moderate to Severe Plaque Psoriasis Medications Consumption Value & Forecasts, 2021-2032, US$ Million Figure 46. United States Moderate to Severe Plaque Psoriasis Medications Sales Quantity, 2021-2032, (K Units) Figure 47. by Type, United States Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share, 2025 VS 2032 Figure 48. by Application, United States Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share, 2025 VS 2032 Figure 49. Europe Moderate to Severe Plaque Psoriasis Medications Sales Quantity, 2021-2032, (K Units) Figure 50. by Type, Europe Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share, 2025 VS 2032 Figure 51. by Application, Europe Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share, 2025 VS 2032 Figure 52. China Moderate to Severe Plaque Psoriasis Medications Sales Quantity, 2021-2032, (K Units) Figure 53. by Type, China Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share, 2025 VS 2032 Figure 54. by Application, China Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share, 2025 VS 2032 Figure 55. Japan Moderate to Severe Plaque Psoriasis Medications Sales Quantity, 2021-2032, (K Units) Figure 56. by Type, Japan Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share, 2025 VS 2032 Figure 57. by Application, Japan Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share, 2025 VS 2032 Figure 58. South Korea Moderate to Severe Plaque Psoriasis Medications Sales Quantity, 2021-2032, (K Units) Figure 59. by Type, South Korea Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share, 2025 VS 2032 Figure 60. by Application, South Korea Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share, 2025 VS 2032 Figure 61. Southeast Asia Moderate to Severe Plaque Psoriasis Medications Sales Quantity, 2021-2032, (K Units) Figure 62. by Type, Southeast Asia Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share, 2025 VS 2032 Figure 63. by Application, Southeast Asia Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share, 2025 VS 2032 Figure 64. India Moderate to Severe Plaque Psoriasis Medications Sales Quantity, 2021-2032, (K Units) Figure 65. by Type, India Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share, 2025 VS 2032 Figure 66. by Application, India Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share, 2025 VS 2032 Figure 67. Middle East & Africa Moderate to Severe Plaque Psoriasis Medications Sales Quantity, 2021-2032, (K Units) Figure 68. by Type, Middle East & Africa Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share, 2025 VS 2032 Figure 69. by Application, Middle East & Africa Moderate to Severe Plaque Psoriasis Medications Sales Quantity Market Share, 2025 VS 2032 Figure 70. Research Methodology Figure 71. Breakdown of Primary Interviews Figure 72. Bottom-up Approaches Figure 73. Top-down Approaches
お見積>
サンプルお申込み>
今すぐ購入>
PDFダウンロード>
当社から購入のメリット
多言語（英語、日本語）のサンプル提供
プロフェッショナルな日本語翻訳を提供
請求書、クレジットカードでのお支払いが可能です
必要なチャプターやカスタマイズされたレポートの注文が可能
購入後、アナリストに直接連絡することができます
購入方法
必要な言語とバージョンのレポート選択
レポート要件と見積もり依頼
電子メールによる注文
レポートの入手（英語版は2～4営業日、日本語版は8～10営業日）
クレジットカード決済、オフライン振込に対応（後払い可）
クライアント様（例）
050-5840-2692 日本
0081-50-5840-2692 グローバル
info@globalreports.jp